Država: Malta
Jezik: engleski
Izvor: HMA (Heads of Medicines Agencies)
oxantel embonate 40.06 mg, praziquantel 10 mg, pyrantel embonate 9.99 mg
Vetoquinol
QP52AA51
Tablet
praziquantel, combinations
Dogs
2011-05-19
VETOQUINOL/DOLPAC SMALL DOGS/EUROPEAN RENEWAL JUNE 2011 1/5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Austria Belgium Cyprus Malta Czech Republic Netherlands Greece Portugal Slovakia Hungary Slovenia Germany Finland Dolpac small dogs tablets France Luxembourg Dolpac 2 comprimé UK-Ireland-Italy Dolpac Tablets for Small Dogs Spain Poland Dolpac small dogs tablets for 1-6 kg Denmark Sweden Dolpac vet small dogs tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains Active substances Oxantel 40.06 mg (equivalent to 111.8 mg of oxantel embonate) Pyrantel 9.99 mg (equivalent to 28.8 mg of pyrantel embonate) Praziquantel 10.00 mg Excipient to one 190 mg divisible tablet Excipients For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablet Pale yellow to yellow oblong tablet with breaking line; 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For curative treatment of dogs harbouring mixed parasitic infestations with the following adult stages of nematode and cestode species: Nematodes: _ _ _Toxocara canis_ _ _ _Toxascaris leonina _ _ _ _Ancylostoma caninum_ VETOQUINOL/DOLPAC SMALL DOGS/EUROPEAN RENEWAL JUNE 2011 2/5 _ _ _Uncinaria stenocephala _ _ _ _Trichuris vulpis_ Cestodes: _ _ _Dipylidium caninum_ _ _ _ _ _ _ _Taenia _spp_ _ _ _ _Echinococcus multilocularis_ _ _ _Echinococcus granulosus_ 4.3 CONTRAINDICATIONS See section 4.8. 4.4 SPECIAL WARNINGS FOR E Pročitajte cijeli dokument
VETOQUINOL/DOLPAC SMALL DOGS/EUROPEAN RENEWAL JUNE 2011 1/10 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Austria Belgium Cyprus Malta Czech Republic Netherlands Greece Portugal Slovakia Hungary Slovenia Germany Finland Dolpac small dogs tablets France Luxembourg Dolpac 2 comprimé UK-Ireland-Italy Dolpac Tablets for Small Dogs Spain Poland Dolpac small dogs tablets for 1-6 kg Denmark Sweden Dolpac vet small dogs tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains Active substances Oxantel 40.06 mg (equivalent to 111.8 mg of oxantel embonate) Pyrantel 9.99 mg (equivalent to 28.8 mg of pyrantel embonate) Praziquantel 10.00 mg Excipient to one 190 mg divisible tablet Excipients For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablet Pale yellow to yellow , elongated, divisible oblong tablet with breaking line; 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For curative treatment of dogs harbouring mixed parasitic infestations with the following adult stages of nematode and cestode species: Nematodes: _ _ _Toxocara canis_ _ _ _Toxascaris leonina _ _ _ _Ancylostoma caninum_ VETOQUINOL/DOLPAC SMALL DOGS/EUROPEAN RENEWAL JUNE 2011 2/10 _ _ _Uncinaria stenocephala _ _ _ _Trichuris vulpis_ Cestodes: _ _ _Dipylidium caninum_ _ _ _ _ _ _ _Taenia _spp_ _ _ _ _Echinococcus multilocularis_ _ _ _Echinococcus granulosus_ 4.3 CONTRAINDICATIONS See section 4.8. Pročitajte cijeli dokument